Ensign Peak Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.8M | Sell |
177,034
-57,687
| -25% | -$25.7M | 0.13% | 143 |
|
|
2025
Q1 | $114M | Sell |
234,721
-40,361
| -15% | -$19.6M | 0.22% | 96 |
|
|
2024
Q4 | $111M | Buy |
275,082
+97,611
| +55% | +$39.3M | 0.2% | 103 |
|
|
2024
Q3 | $82.5M | Sell |
177,471
-6,233
| -3% | -$2.9M | 0.15% | 125 |
|
|
2024
Q2 | $86.1M | Sell |
183,704
-40,789
| -18% | -$19.1M | 0.16% | 115 |
|
|
2024
Q1 | $93.8M | Sell |
224,493
-436,034
| -66% | -$182M | 0.17% | 115 |
|
|
2023
Q4 | $269M | Sell |
660,527
-94,975
| -13% | -$38.6M | 0.53% | 42 |
|
|
2023
Q3 | $263M | Sell |
755,502
-11,990
| -2% | -$4.17M | 0.56% | 39 |
|
|
2023
Q2 | $270M | Buy |
767,492
+18,132
| +2% | +$6.38M | 0.55% | 42 |
|
|
2023
Q1 | $236M | Buy |
749,360
+321,980
| +75% | +$101M | 0.51% | 50 |
|
|
2022
Q4 | $123M | Buy |
427,380
+31,689
| +8% | +$9.15M | 0.28% | 89 |
|
|
2022
Q3 | $115M | Buy |
395,691
+30,810
| +8% | +$8.92M | 0.28% | 86 |
|
|
2022
Q2 | $103M | Buy |
364,881
+31,572
| +9% | +$8.9M | 0.24% | 100 |
|
|
2022
Q1 | $87M | Buy |
333,309
+37,631
| +13% | +$9.82M | 0.18% | 113 |
|
|
2021
Q4 | $64.9M | Sell |
295,678
-151,534
| -34% | -$33.3M | 0.12% | 152 |
|
|
2021
Q3 | $81.1M | Sell |
447,212
-158,321
| -26% | -$28.7M | 0.17% | 128 |
|
|
2021
Q2 | $122M | Buy |
605,533
+59,685
| +11% | +$12M | 0.25% | 102 |
|
|
2021
Q1 | $117M | Buy |
545,848
+4,116
| +0.8% | +$884K | 0.25% | 101 |
|
|
2020
Q4 | $128M | Buy |
541,732
+40,970
| +8% | +$9.68M | 0.29% | 87 |
|
|
2020
Q3 | $136M | Sell |
500,762
-122,808
| -20% | -$33.4M | 0.34% | 66 |
|
|
2020
Q2 | $181M | Sell |
623,570
-175,878
| -22% | -$51.1M | 0.49% | 49 |
|
|
2020
Q1 | $190M | Sell |
799,448
-10,669
| -1% | -$2.54M | 0.64% | 37 |
|
|
2019
Q4 | $177M | Buy |
+810,117
| New | +$177M | 0.47% | 54 |
|